136 related articles for article (PubMed ID: 2464269)
21. Use of monoclonal antibodies to glial fibrillary acidic protein in the cytologic diagnosis of brain tumors.
Chen Y; Zhang YX
Acta Cytol; 1989; 33(6):922-8. PubMed ID: 2588925
[TBL] [Abstract][Full Text] [Related]
22. Neurofilament H immunoreaction in oligodendrogliomas as demonstrated by a new polyclonal antibody.
Dehghani F; Maronde E; Schachenmayr W; Korf HW
Acta Neuropathol; 2000 Aug; 100(2):122-30. PubMed ID: 10963358
[TBL] [Abstract][Full Text] [Related]
23. Systematic immunohistochemical profiling of 378 brain tumors with 37 antibodies using tissue microarray technology.
Ikota H; Kinjo S; Yokoo H; Nakazato Y
Acta Neuropathol; 2006 May; 111(5):475-82. PubMed ID: 16598485
[TBL] [Abstract][Full Text] [Related]
24. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
Reyaz N; Tayyab M; Khan SA; Siddique T
J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
[TBL] [Abstract][Full Text] [Related]
25. [Immunohistochemistry in oligodendrogliomas].
Hilbig A; Barbosa-Coutinho LM; Netto GC; Bleil CB; Toscani NV
Arq Neuropsiquiatr; 2006 Mar; 64(1):67-71. PubMed ID: 16622556
[TBL] [Abstract][Full Text] [Related]
26. Oligodendrogliomas in relation to astrocytes differentiation. Clinicopathologic and immunohistochemical study.
Tena-Suck ML; Moreno-Jiménez S; Alonso M; Aguirre-Crux L; Sánchez A
Ann Diagn Pathol; 2008 Oct; 12(5):313-21. PubMed ID: 18774492
[TBL] [Abstract][Full Text] [Related]
27. Characterization of refractile eosinophilic granular cells in oligodendroglial tumors.
Yoshida T; Nakazato Y
Acta Neuropathol; 2001 Jul; 102(1):11-9. PubMed ID: 11547945
[TBL] [Abstract][Full Text] [Related]
28. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical studies on cellular character of microtumors induced by ethylnitrosourea in the rat brain utilizing anti-Leu 7 and anti-glial fibrillary acidic protein antibodies.
Yoshino T; Motoi M; Ogawa K
Acta Neuropathol; 1985; 66(2):167-9. PubMed ID: 2990142
[TBL] [Abstract][Full Text] [Related]
30. [An immunohistochemical and ultrastructural study of 243 gliomas with reference to the prognosis].
Bian XW
Zhonghua Bing Li Xue Za Zhi; 1992 Jun; 21(3):171-3. PubMed ID: 1335846
[TBL] [Abstract][Full Text] [Related]
31. Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors.
Shukla B; Agarwal S; Suri V; Pathak P; Sharma MC; Gupta D; Sharma BS; Suri A; Halder A; Sarkar C
Neurol India; 2009; 57(5):559-66. PubMed ID: 19934553
[TBL] [Abstract][Full Text] [Related]
32. Oligodendroglioma: pathology and molecular biology.
Engelhard HH; Stelea A; Cochran EJ
Surg Neurol; 2002 Aug; 58(2):111-7; discussion 117. PubMed ID: 12453646
[TBL] [Abstract][Full Text] [Related]
33. Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2.
Rousseau A; Nutt CL; Betensky RA; Iafrate AJ; Han M; Ligon KL; Rowitch DH; Louis DN
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1149-56. PubMed ID: 17146289
[TBL] [Abstract][Full Text] [Related]
34. Antiapoptotic Bcl-2 family protein expression increases with progression of oligodendroglioma.
Deininger MH; Weller M; Streffer J; Meyermann R
Cancer; 1999 Nov; 86(9):1832-9. PubMed ID: 10547558
[TBL] [Abstract][Full Text] [Related]
35. Murine Esophagus Expresses Glial-Derived Central Nervous System Antigens.
Kapitza C; Chunder R; Scheller A; Given KS; Macklin WB; Enders M; Kuerten S; Neuhuber WL; Wörl J
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33810144
[TBL] [Abstract][Full Text] [Related]
36. Molecular markers that identify human astrocytomas and oligodendrogliomas.
Popko B; Pearl DK; Walker DM; Comas TC; Baerwald KD; Burger PC; Scheithauer BW; Yates AJ
J Neuropathol Exp Neurol; 2002 Apr; 61(4):329-38. PubMed ID: 11939588
[TBL] [Abstract][Full Text] [Related]
37. Immunolocalization of the oligodendrocyte transcription factor 1 (Olig1) in brain tumors.
Azzarelli B; Miravalle L; Vidal R
J Neuropathol Exp Neurol; 2004 Feb; 63(2):170-9. PubMed ID: 14989603
[TBL] [Abstract][Full Text] [Related]
38. [Significance of immunohistochemistry for neuro-oncology. VI. Occurrence, localization and distribution of glial fibrillary acid protein (GFAP) in 820 tumors].
Gottschalk J; Szymaś J
Zentralbl Allg Pathol; 1987; 133(4):319-30. PubMed ID: 3425011
[TBL] [Abstract][Full Text] [Related]
39. Glial fibrillary acidic protein (GFAP) in oligodendrogliomas: a reflection of transient GFAP expression by immature oligodendroglia.
Jagadha V; Halliday WC; Becker LE
Can J Neurol Sci; 1986 Nov; 13(4):307-11. PubMed ID: 3536047
[TBL] [Abstract][Full Text] [Related]
40. The neuroendocrine and neural profiles of neuroblastomas, ganglioneuroblastomas, and ganglioneuromas.
Molenaar WM; Baker DL; Pleasure D; Lee VM; Trojanowski JQ
Am J Pathol; 1990 Feb; 136(2):375-82. PubMed ID: 1689542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
